Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Dr. Felt Medical Office
mi
from
Oakland, CA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Dr. Felt Medical Office
mi
from
Oakland, CA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Stanford University
mi
from
Stanford, CA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Yale University School of Medicine
mi
from
New Haven, CT
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Norwalk Hospital
mi
from
Norwalk, CT
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Norwalk Hospital
mi
from
Norwalk, CT
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
George Washington University
mi
from
Washington,
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Florida Hospital Celebration Health
mi
from
Celebration, FL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Florida Hospital Celebration Health
mi
from
Celebration, FL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Research Alliance, Inc.
mi
from
Clearwater, FL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Research Alliance, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Pensacola Lung Group
mi
from
Pensacola, FL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Pensacola Lung Group
mi
from
Pensacola, FL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Indian River Med. Ctr.
mi
from
Vero Beach, FL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Indian River Med. Ctr.
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Atlanta Institute For Medical Research, Inc
mi
from
Atlanta, GA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Atlanta Institute For Medical Research, Inc
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Pulmonary & Critical Care of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Idaho Falls Infectious Diseases PLLC
mi
from
Idaho Falls, ID
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Idaho Falls Infectious Diseases PLLC
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
West Suburban Hospital
mi
from
Oak Park, IL
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
West Suburban Hospital
mi
from
Oak Park, IL
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Infectious Disease Of Indiana Psc
mi
from
Carmel, IN
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Infectious Disease Of Indiana Psc
mi
from
Carmel, IN
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Cotton-O-Neil Clinical Research Center
mi
from
Topeka, KA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Cotton-O-Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Franklin Square Hospital
mi
from
Baltimore, MD
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Franklin Square Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Henry Ford Hospital, Transplant Institute
mi
from
Detriot, MI
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Henry Ford Hospital, Transplant Institute
mi
from
Detriot, MI
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
University Of Missouri-Columbia
mi
from
Columbia, MO
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
University Of Missouri-Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Mercury Street Medical Group, Pllc
mi
from
Butte, MT
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Creighton University Medical Center
mi
from
Omaha, NE
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Morristown Memorial Hospital
mi
from
Mornstown, NJ
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Morristown Memorial Hospital
mi
from
Mornstown, NJ
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Staten Island University Hospital
mi
from
Staten Island, NY
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Mission Hospital, Inc
mi
from
Asheville, NC
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Lehigh Valley Hospital
mi
from
Allentown, PA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
The Milton S Hershey Medical Center Of Penn. State Univ.
mi
from
Hershey, PA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
The Milton S Hershey Medical Center Of Penn. State Univ.
mi
from
Hershey, PA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Palmetto Nephrology Pa
mi
from
Orangeburg, SC
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Palmetto Nephrology Pa
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
S. Carolina Pharmaceutical Research
mi
from
Spartanburg, SC
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
S. Carolina Pharmaceutical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Texas Health Presbyterian Dallas
mi
from
Dallas, TX
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Texas Health Presbyterian Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Michael E. De Bakey Veteran Affairs Medical Center
mi
from
Houston, TX
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Michael E. De Bakey Veteran Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Sonterra Clinical Research
mi
from
San Antonio, TX
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Sonterra Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Intermountain Medical Center
mi
from
Murray, UT
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
University of Utah Medical Center
mi
from
Salt Lake City, UT
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
University of Utah Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Mcguire Va Medical Center
mi
from
Richmond, VA
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated:  12/7/2015
Local Institution
mi
from
Ciudad Autonoma Buenos Aires,
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Status: Enrolling
Updated: 12/7/2015
Local Institution
mi
from
Ciudad Autonoma Buenos Aires,
Click here to add this to my saved trials
Protocolized Diuretic Strategy in Cardiorenal Failure
Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial
Status: Enrolling
Updated:  12/7/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Protocolized Diuretic Strategy in Cardiorenal Failure
Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial
Status: Enrolling
Updated: 12/7/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Technique for Successful Ultrasound-guided Peripheral Vascular Access
Technique for Successful Ultrasound-guided Peripheral Vascular Access
Status: Enrolling
Updated:  12/7/2015
University of Iowa Hosptials and Clinics
mi
from
Iowa City, IA
Technique for Successful Ultrasound-guided Peripheral Vascular Access
Technique for Successful Ultrasound-guided Peripheral Vascular Access
Status: Enrolling
Updated: 12/7/2015
University of Iowa Hosptials and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology
Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology Requiring Neonatal Surgery
Status: Enrolling
Updated:  12/7/2015
University of Michigan/ CS Mott Children's Hospital
mi
from
Ann Arbor, MI
Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology
Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology Requiring Neonatal Surgery
Status: Enrolling
Updated: 12/7/2015
University of Michigan/ CS Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
VA GLAHS - David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
VA GLAHS - David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
UCLA Medical Center
mi
from
Los Angeles, CA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Cardiovascular Consultants Medical Group
mi
from
San Ramon, CA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Cardiovascular Consultants Medical Group
mi
from
San Ramon, CA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Cardiovascular Consultants Medical Group
mi
from
Walnut Creek, CA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Cardiovascular Consultants Medical Group
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
St Francis Hospital and Medical Center, Hoffman Heart Institute
mi
from
Hartford, CT
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
St Francis Hospital and Medical Center, Hoffman Heart Institute
mi
from
Hartford, CT
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Jim Moran Heart & Vascular Center
mi
from
Ft Lauderdale, FL
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Jim Moran Heart & Vascular Center
mi
from
Ft Lauderdale, FL
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Florida Institute for Cardiovascular Care
mi
from
Hollywood, FL
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Florida Institute for Cardiovascular Care
mi
from
Hollywood, FL
Click here to add this to my saved trials